Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

• Design characteristics of mass balance studies conducted for protein kinase inhibitors

  2026 Cancer Chemotherapy and Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  0

  citations
• Lower Dose‐Normalized Tacrolimus Exposure in CYP3A5 *6 vs. *3 Loss‐of‐Function Allele Carriers: A Longitudinal Retrospective Real‐World Study in Kidney Transplant Recipients

  2025 Clinical Pharmacology & Therapeutics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  4

  citations
• Effect of CYP3A4 Methylation on Tacrolimus Pharmacokinetics

  2025 Therapeutic Drug Monitoring article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  1

  citations
• Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects

  2025 Clinical Pharmacology & Therapeutics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  9

  citations
• The pharmacogenomic landscape of an Indigenous Australian population

  2023 Frontiers in Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  14

  citations
• Physiologically based pharmacokinetic modeling of tacrolimus for food–drug and CYP3A drug–drug–gene interaction predictions

  2023 CPT Pharmacometrics & Systems Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  22

  citations
• Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity

  2022 Frontiers in Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  29

  citations
• Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation

  2021 Drug Discovery Today article Medicine Renal Transplantation Outcomes and Treatments Open access

  24

  citations
• Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

  2021 Therapeutic Drug Monitoring article Medicine Renal Transplantation Outcomes and Treatments Open access

  208

  citations
• Comparison of the Impact of Pharmacogenetic Variability on the PK of Slow Release and Immediate Release Tacrolimus Formulations

  2020 Genes article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  9

  citations
• Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

  2020 Journal of Clinical Medicine review Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  186

  citations
• The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients

  2020 Frontiers in Pharmacology article Medicine Renal Transplantation Outcomes and Treatments Open access

  72

  citations

12 results